BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16936297)

  • 1. Chronic progesterone antagonist-estradiol therapy suppresses breakthrough bleeding and endometrial proliferation in a menopausal macaque model.
    Slayden OD; Zelinski MB; Chwalisz K; Hess-Stumpp H; Brenner RM
    Hum Reprod; 2006 Dec; 21(12):3081-90. PubMed ID: 16936297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: a pilot study.
    Heikinheimo O; Vani S; Carpén O; Tapper A; Härkki P; Rutanen EM; Critchley H
    Hum Reprod; 2007 Sep; 22(9):2515-22. PubMed ID: 17636280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible suppression of menstruation with progesterone antagonists in rhesus macaques.
    Slayden OD; Chwalisz K; Brenner RM
    Hum Reprod; 2001 Aug; 16(8):1562-74. PubMed ID: 11473944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an antiprogestin onapristone on the endometrium of bonnet monkeys: morphometric and ultrastructural studies.
    Gopalkrishnan K; Katkam RR; Sachdeva G; Kholkute SD; Padwal V; Puri CP
    Biol Reprod; 2003 Jun; 68(6):1959-67. PubMed ID: 12606448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium.
    Slayden OD; Nayak NR; Burton KA; Chwalisz K; Cameron ST; Critchley HO; Baird DT; Brenner RM
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2668-79. PubMed ID: 11397870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: morphometric assessment of the uterus and oviduct.
    Slayden OD; Zelinski-Wooten MB; Chwalisz K; Stouffer RL; Brenner RM
    Hum Reprod; 1998 Feb; 13(2):269-77. PubMed ID: 9557821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flutamide counteracts the antiproliferative effects of antiprogestins in the primate endometrium.
    Slayden OD; Brenner RM
    J Clin Endocrinol Metab; 2003 Feb; 88(2):946-9. PubMed ID: 12574238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone].
    Philippe E; Faguer B; Engelman A; Charpin C; Loubière R; de Mascarel A; Leduc F; Dupin P; Hemet J; Vauzelle JL
    Pathologica; 1993; 85(1099):475-87. PubMed ID: 8127629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium.
    Chwalisz K; Brenner RM; Fuhrmann UU; Hess-Stumpp H; Elger W
    Steroids; 2000; 65(10-11):741-51. PubMed ID: 11108885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding.
    Rogers PA; Martinez F; Girling JE; Lederman F; Cann L; Farrell E; Tresserra F; Patel N
    Hum Reprod; 2005 Dec; 20(12):3341-7. PubMed ID: 16085661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of endometrial function during sustained delivery of estradiol and estradiol plus progesterone in ovariectomized rats.
    Cason Z; Benghuzzi H; Tucci M; Scott A; England B
    Biomed Sci Instrum; 2000; 36():221-6. PubMed ID: 10834236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with a progesterone antagonist ZK 98.299 delays endometrial development without blocking ovulation in bonnet monkeys.
    Ishwad PC; Katkam RR; Hinduja IN; Chwalisz K; Elger W; Puri CP
    Contraception; 1993 Jul; 48(1):57-70. PubMed ID: 8403906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
    Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential growth stimulation of mammary glands over uterine endometrium in female rats by a naturally occurring estradiol-17beta-fatty acid ester.
    Mills LH; Lee AJ; Parlow AF; Zhu BT
    Cancer Res; 2001 Aug; 61(15):5764-70. PubMed ID: 11479213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-progesterone therapy in perimenopausal women.
    Budoff PW; Sommers SC
    J Reprod Med; 1979 May; 22(5):241-7. PubMed ID: 222901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding profiles and effects on the endometrium for women using a novel combination of transdermal oestradiol and natural progesterone cream as part of a continuous combined hormone replacement regime.
    Vashisht A; Wadsworth F; Carey A; Carey B; Studd J
    BJOG; 2005 Oct; 112(10):1402-6. PubMed ID: 16167944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
    Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
    In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiprogestin-releasing intrauterine devices: a novel approach to endometrial contraception.
    Nayak NR; Slayden OD; Mah K; Chwalisz K; Brenner RM
    Contraception; 2007 Jun; 75(6 Suppl):S104-11. PubMed ID: 17531599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
    Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.